Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
DAIDS Boss Muses on the Future of HIV Prevention Research

Below are some of Dr. Dieffenbach’s rather intentionally provocative ideas about specific HIV prevention research candidates—challenges and promises, and the questions they may raise for the next clinical trial research network structure.

Published
11 hours ago
From
AVAC
Hate, discrimination lead to rise of HIV in Russia, experts say

"Homophobia and a negative view of drug addicts, as well as the obscure legal status of prostitutes, have all led to the fact that Russia uses less than half of all of the methods that have been scientifically proven to prevent the spread of HIV around the world," Vadim Pokrovskiy, head of the Russian Federal AIDS Center, said.

Published
13 hours ago
From
Deutsche Welle
AIDS—learning from history (and human beings)

After 400 pages of exhaustive (and occasionally exhausting) remembering, Michael Merson and Stephen Inrig conclude their “useful history” (The AIDS Pandemic: Searching for a Global Response, 2017) with seven lessons.

Published
13 hours ago
From
The Lancet
Getting to GIPA 2.0: from Science to Activism

Bruno Spire is a researcher living with HIV and a senior scientist at the French National Institute for Medical Research (INSERM). Bruno has been a member of the International AIDS Society (IAS) since 2008 and has been on the IAS Governing Council for the European region since 2016. Since 1988, he has been a member of AIDES, the main nongovernmental HIV organization in France, and he is now honorary President. Bruno is a scientist, but more so, he is an advocate on HIV community-based research. In this personal narrative, Bruno shares his experience connecting science and activism and how to apply that concept to the GIPA principles. This is his story …

Published
19 October 2017
From
IAS
How Harvey Weinstein Embroiled an AIDS Foundation in Conflict

A $600,000 “shady deal” at an amfAR fundraiser leads to investigations and resignations.

Published
19 October 2017
From
Poz
Malawi:Meeting Men Halfway - HIV Clinics Are Going Mobile to Reach Toughest Patients

For decades, we've struggled to solve the riddle: How do you get reluctant men to test for HIV. Could we finally have an answer?

Published
18 October 2017
From
AllAfrica
Backlash from civil society as PEPFAR announces three-year strategy

The President’s Emergency Plan for AIDS Relief (PEPFAR) is to accelerate efforts in just 13 countries under its news strategy. But critics say this narrowed focus could lead to a resurgence of the HIV epidemic.

Published
18 October 2017
From
AVERT
Patients risk being left behind as foreign donors pull the plug on HIV/AIDS in Vietnam

Vietnam is facing an administrative nightmare as a result of transitioning its HIV/AIDS treatment program to health insurance as foreign funds will come to a full stop in 2020 as Vietnam has reached middle income status.

Published
18 October 2017
From
VN Express
PrEP would save the NHS money, in numerous scenarios

A pre-exposure prophylaxis (PrEP) programme for men who have sex with men in the UK would not only be cost-effective, but actually cost-saving (in other words, both

Published
17 October 2017
By
Roger Pebody
Gilead Continues To Block Ireland From Sourcing Generic Truvada

Gilead Sciences, the company that supplies Ireland with the drug Truvada, will have a full court hearing in mid-October to determine whether the Irish Health and Safety Executive (HSE) can source a generic analogue of the drug from the pharmaceutical giant’s competitors. In July, GCN reported that Gilead was taking legal action to stop the HSE from securing generic drug from Actavis and Mylan, the company’s competitors, for the purposes of HIV prevention as PrEP.

Published
16 October 2017
From
Gay Community News
← First12345...632Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.